These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 25441301)
1. Fc-sialylated IgGs in intravenous immunoglobulins are not responsible for induction of regulatory T cells. Ramakrishna C; Cantin EM J Allergy Clin Immunol; 2014 Dec; 134(6):1469. PubMed ID: 25441301 [No Abstract] [Full Text] [Related]
3. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883 [TBL] [Abstract][Full Text] [Related]
4. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin. Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174 [TBL] [Abstract][Full Text] [Related]
5. The antiinflammatory activity of IgG: the intravenous IgG paradox. Nimmerjahn F; Ravetch JV J Exp Med; 2007 Jan; 204(1):11-5. PubMed ID: 17227911 [TBL] [Abstract][Full Text] [Related]
6. Editorial: Strangers with candy: policing the lungs with C-type lectins. Kulkarni R; Jeyaseelan S J Leukoc Biol; 2013 Sep; 94(3):387-9. PubMed ID: 23990658 [No Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation. Maddur MS; Trinath J; Rabin M; Bolgert F; Guy M; Vallat JM; Magy L; Balaji KN; Kaveri SV; Bayry J Cell Mol Immunol; 2015 Sep; 12(5):650-2. PubMed ID: 25482074 [No Abstract] [Full Text] [Related]
8. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819 [TBL] [Abstract][Full Text] [Related]
9. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2. Röck J; Schneider E; Grün JR; Grützkau A; Küppers R; Schmitz J; Winkels G Eur J Immunol; 2007 Dec; 37(12):3564-75. PubMed ID: 18022864 [TBL] [Abstract][Full Text] [Related]
10. T(S) cells and immune tolerance induction: a regulatory renaissance? Feinberg MB; Silvestri G Nat Immunol; 2002 Mar; 3(3):215-7. PubMed ID: 11875459 [No Abstract] [Full Text] [Related]
11. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399 [TBL] [Abstract][Full Text] [Related]
12. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542 [TBL] [Abstract][Full Text] [Related]
13. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198 [TBL] [Abstract][Full Text] [Related]
14. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049 [TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. McVicar DW; Burshtyn DN Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646 [TBL] [Abstract][Full Text] [Related]
16. [Accessory molecules of the intercellular interaction of T-lymphocytes as physiologically active peptides of the cell membrane]. Leskov VP; Pisarev VM Vestn Akad Med Nauk SSSR; 1989; (4):83-9. PubMed ID: 2471368 [No Abstract] [Full Text] [Related]
17. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Chang CC; Ciubotariu R; Manavalan JS; Yuan J; Colovai AI; Piazza F; Lederman S; Colonna M; Cortesini R; Dalla-Favera R; Suciu-Foca N Nat Immunol; 2002 Mar; 3(3):237-43. PubMed ID: 11875462 [TBL] [Abstract][Full Text] [Related]
19. Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts. Cortesini NS; Colovai AI; Manavalan JS; Galluzzo S; Naiyer AJ; Liu J; Vlad G; Kim-Schulze S; Scotto L; Fan J; Cortesini R Transpl Immunol; 2004; 13(2):73-82. PubMed ID: 15380537 [No Abstract] [Full Text] [Related]
20. Mechanisms of immune regulation by IVIG. Ballow M Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]